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ABSTRACT
Background
In Africa, women tested for HIV during antenatal care are counselled to share with their
partner their HIV test result and to encourage partners to undertake HIV testing. We
investigate, among women tested for HIV within a prevention of mother-to-child transmission
of HIV (PMTCT) programme, the key moments for disclosure of their own HIV status to their
partner and the impact on partner HIV testing.
Methods and Findings
Within the Ditrame Plus PMTCT project in Abidjan, 546 HIV-positive and 393 HIV-negative
women were tested during pregnancy and followed-up for two years after delivery.
Circumstances, frequency, and determinants of disclosure to the male partner were estimated
according to HIV status. The determinants of partner HIV testing were identified according to
women’s HIV status. During the two-year follow-up, disclosure to the partner was reported by
96.7% of the HIV-negative women, compared to 46.2% of HIV-positive women (v
2 ¼ 265.2,
degrees of freedom [df]¼1, p , 0.001). Among HIV-infected women, privileged circumstances
for disclosure were just before delivery, during early weaning (at 4 mo to prevent HIV postnatal
transmission), or upon resumption of sexual activity. Formula feeding by HIV-infected women
increased the probability of disclosure (adjusted odds ratio 1.54, 95% confidence interval 1.04–
2.27, Wald test ¼ 4.649, df ¼ 1, p ¼ 0.031), whereas household factors such as having a co-
spouse or living with family reduced the probability of disclosure. The proportion of male
partners tested for HIV was 23.1% among HIV-positive women and 14.8% among HIV-negative
women (v
2 ¼ 10.04, df ¼ 1, p ¼ 0.002). Partners of HIV-positive women who were informed of
their wife’s HIV status were more likely to undertake HIV testing than those not informed
(37.7% versus 10.5%, v
2 ¼ 56.36, df ¼ 1, p , 0.001).
Conclusions
In PMTCT programmes, specific psychosocial counselling and support should be provided to
women during the key moments of disclosure of HIV status to their partners (end of pregnancy,
weaning, and resumption of sexual activity). This support could contribute to improving
women’s adherence to the advice given to prevent postnatal and sexual HIV transmission.
The Editors’ Summary of this article follows the references.
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At the end of 2006, 63% of all people livingwith HIV/AIDS
lived in sub-Saharan Africa [1]. Programmatic strategies for
the prevention of sexual transmission of HIV need urgent
development, assessment, and scale-up [2]. In African
countries confronted with an HIV/AIDS pandemic, most
cases of sexual transmission of HIV occur within stable
relationships. In sub-Saharan Africa, Prevention within the
couple is therefore of primary importance. In 2006, 59% of
HIV-infected adults were women [1], and most of them had
contracted HIV through sexual transmission from their stable
partner [3].
Most studies available on sexual relations within the couple
in sub-Saharan Africa have shown lack of prevention of
sexual transmission of HIV within stable relationships [4,5].
The prevention of sexual transmission of HIV within the
couple involves HIV testing for each member and the
systematic use of condoms if one of the members is HIV-
positive or until both members have been tested HIV-
negative and have adopted safe sex practices. Research
studies exploring how the risk of sexual transmission of
HIV infection is managed within couples in sub-Saharan
Africa show that these simple principles are unfortunately
rarely implemented [6–8]. Sexual relations with the regular
partner are rarely protected, because they are perceived as
risk-free [4,5]. Nevertheless, in populations with a high
prevalence of HIV infection, those who engage in conjugal
sexual relations are at risk of infection. HIV testing of each
partner and conjugal exchange of information on serostatus
remain the only way to evaluate the risk of HIV transmission
in conjugal sexual relations. Nonetheless, HIV testing has
remained infrequent in Africa [9].
With the implementation of prevention of mother-to-child
transmission of HIV (PMTCT) programmes in African
countries, prenatal HIV counselling and testing is offered to
many pregnant women. Hence these women are often the
ﬁrst to be HIV tested within couples [10]. These women are
then counselled to share with their partner their own HIV
test result, and they become responsible for encouraging
their partner to undertake HIV testing. But the dialogue on
sexual activity or HIV/AIDS within the couple is not easy,
especially when women discover that they are HIV-infected
[11–13]. Available studies have documented women’s experi-
ence of disclosure to their partner and reported the barriers
to disclosure, such as women’s fears related to stigmatisation,
family rejection, breach of conﬁdentiality, or accusations of
inﬁdelity [14]. These studies, however, did not explore the
dynamic of the woman’s decision when she informed her
partner of her HIV status. Better understanding of the
circumstances and events leading to women’s disclosure to
their partner is required in order to better support them in
this process. In this paper, we investigated which women who
accepted HIV testing within a PMTCT programme reported
their HIV status to their partner, and when they did so
between HIV testing in pregnancy and 24 months after
delivery. We also examined whether or not telling the partner
had led to HIV testing of the partner.
Methods
Ditrame Plus Research Programme
The ANRS 1201/1202/1253 Ditrame Plus programme was
the PMTCT research effort implemented in Abidjan, Co ˆte
d’Ivoire in March 2001 [15–17]. HIV testing was systematically
offered at the ﬁrst antenatal consultation to all pregnant
women aged 18 y or over who attended one of the seven
antenatal clinics located in two poor, densely populated
districts of Abidjan. After signing an informed consent form,
women were regularly followed up for 2 y after delivery, every
3 mo during the ﬁrst year and every 6 mo during the second
year. The Ditrame Plus study was granted ethical permission
in Co ˆte d’Ivoire from the ethical committee of the National
AIDS Control Programme, and in France from the institu-
tional review board of the French Agence Nationale de
Recherches sur le Sida (ANRS).
Consenting HIV-positive women were systematically in-
vited to be included in a cohort offering PMTCT interven-
tions (fully described elsewhere [16,17]): short-course
peripartum antiretroviral regimens and exclusive formula
feeding from birth until 9 mo postpartum or exclusive breast-
feeding with early cessation at 4 mo. A subgroup of HIV-
negative pregnant women were also included and followed up
in another cohort offering HIV counselling, contraception
access, and access to care. During pre- and post-test
counselling and postpartum follow-up, all women were
informed regarding sexually transmitted infections, including
HIV/AIDS, and the use of condoms. After delivery, they were
also offered postnatal contraception for 1 mo after delivery
and free provision of contraceptives including condoms.
HIV-negative and HIV-positive women attended different
clinics. During each follow-up visit, standardised question-
naires were administered to all women to document the
disclosure of HIV status to the partner, the resumption of
sexual activity, and sociodemographic characteristics. The
same standardised questionnaire was used in the two
prospective cohorts of HIV-positive and HIV-negative wom-
en for comparative analysis.
Population
From March 2001 to June 2003, 980 pregnant women who
were tested for HIV during antenatal consultation and who
had delivered were included within the Ditrame Plus
programme. The average age of gestation of HIV-infected
pregnant women was 36 wk [range 26–43] at enrolment.
Excluded from this analysis were 23 (2.3%) women lost to
follow-up before the visit scheduled at 1 mo after delivery and
18 (1.8%) women who remained without any partner during
the follow-up period. A total of 939 women, of whom 546
were HIV-positive and 393 HIV-negative, were included for
this analysis. Remaining in the study through the 18-mo
postpartum appointment were 90% of HIV-negative women
and 85% of HIV-positive women (v
2 ¼ 6.603, degrees of
freedom [df] ¼ 1, p ¼ 0.010).
Disclosure of HIV Status to Partner
We analysed the timing of women’s disclosure of their HIV
status to their partner. As the exact date was not known, we
estimated the disclosure date as the mid-period between the
date of the previous follow-up visit and the date of the visit
when the woman reported having disclosed her status. We
then compared this period to speciﬁc events occurring
between prenatal HIV testing and at the time of resuming
sexual activity. Speciﬁc questions were asked at each visit on
the date of resumption of sexual activity and the date of
cessation of breast-feeding. We analysed the distribution of
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Women and HIV Status Disclosurethe disclosure moment between HIV testing and the end of
the follow-up in relation to delivery, resumption of sexual
activity, and weaning by women who chose to breast-feed.
Figure 1 illustrates the distribution of the time of disclosure,
between HIV testing and the end of the follow-up, in relation
to delivery, resumption of sexual activities, and weaning for
breast-feeding women. (See Text S1 for details of how the
curve was constructed.)
Partner’s HIV Testing
Only partners HIV tested in the 2 y prior to the start of the
Ditrame Plus programme or after the start of the programme,
and whose HIV results were known, were taken into account
in this analysis (15 partners tested for HIV before March 1999
were therefore excluded). The proportion of partners tested
for HIV was described according to the sociodemographic
characteristics of the women, partner, and couple.
Statistical Tools
Statistical analyses were ﬁrst performed on all women
followed up and then within each cohort of women according
to their HIV status. Univariate analyses comprised: variables
related to the woman (i.e., age, religion, education level,
remunerated activity, parity, existence of a co-spouse, type of
habitat, number of cohabiting family members, HIV status,
and clinical AIDS stage for HIV-infected women, according
to the WHO Staging System of HIV Infection and Disease);
variables related to the partner (i.e., age, education level, and
HIV status); and variables related to the infant followed up
within the project (i.e., infant feeding practice implemented
at birth and child survival). Group comparisons used non-
Figure 1. Distribution of the Moment when HIV-Infected Women Disclosed Their Status to Their Male Partner between HIV Testing and the End of
Follow-Up (Ditrame Plus ANRS 1201-1202-1253, Abidjan, 2001–2005)
(A) In relation to delivery and weaning.
(B) In relation to delivery and resumption of sexual activity.
See Text S1 for details on the construction of the curves. me, median.
doi:10.1371/journal.pmed.0040342.g001
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Women and HIV Status Disclosureparametric Mann–Whitney U test for quantitative variables,
and v
2 or Fisher exact tests for qualitative variables. Multi-
variate logistic regressions were performed and included all
variables. All statistical analyses were conducted with SPSS
for Windows (version 12.0).
Results
Characteristics
Table 1 describes the sociodemographic characteristics of
both cohorts of women and their partner. HIV-positive
women were slightly older than their HIV-negative counter-
parts, and more often lived within a polygamous household
(21.8% versus 12.5%, v
2 ¼ 13.53, df ¼ 1, p , 0.001). Male
partners were on average more educated and older than their
wives. All HIV-negative women who delivered live infants
practiced breast-feeding. Among the 546 HIV-positive wom-
en in the study, 243 (44.5%) breast-fed their infant with early
cessation at 17 wk in median (interquartile range [IQR 13–
32]), 283 (51.8%) practiced formula feeding, and for 18 (3.7%)
the information was not reported. Among these women,
88.9% of HIV-infected women who practiced breast-feeding
and 92.5% who practiced formula feeding complied with the
choice expressed prior to delivery (v
2 ¼ 2.147, df ¼ 1, p ¼
0.143).
Women’s Disclosure of Their HIV Status to Their Partner
Most of the HIV-negative women (96.7%) disclosed their
HIV result to their partner, compared to 46.2% of HIV-
positive women (v
2 ¼ 265.2, df ¼ 1, p , 0.001). Among HIV-
infected women who disclosed their HIV status, 82.1%
declared that their partner had a ‘‘positive’’ reaction, i.e.,
was understanding and provided moral support. Among the
women declaring ‘‘negative’’ reactions from their partner
after disclosure, 10 (4%) were blamed for not discussing with
him prior to HIV testing, one (0.4%) experienced violence,
six (2.4%) ended their relationship with their partner, and
ﬁve (2%) declared their partner did not believe their wife’s
positive test result.
As Table 2 indicates, HIV-infected women were less likely
to disclose their HIV status when they lived with their own
family but without their partner than when they lived with
their partner only (adjusted odds ratio [OR] ¼ 0.29, 95%
conﬁdence interval [CI] 0.17–0.50, Wald test¼20.68, df¼1; p
, 0.001) and when they had a co-spouse, versus being the only
wife (adjusted OR ¼ 0.51, 95% CI 0.31–0.83, Wald test ¼ 7.19,
df¼1, p¼0.007). The probability of disclosing to the partner
was higher for HIV-infected women who chose formula
feeding than for those initiating breast-feeding after birth
(OR ¼ 1.54, 95% CI 1.04–2.27, Wald test ¼ 4.649, df ¼ 1; p ¼
0.031). No signiﬁcant correlation was found between disclo-
Table 1. Sociodemographic Characteristics of Women at Enrolment According to Their HIV Status (Ditrame Plus ANRS 1201-1202-1253,
Abidjan, 2001–2005)
Factor Category HIV-Positive Women HIV-Negative Women p-Value
a Overall
Total number 546 393 — 939
Median age in years (IQR) 26 (23–30) 25 (22–29) 0.002 26 (22–30)
Median number of children alive at
time of study (IQR)
2 (1–3) 2 (1–3) 0.371 2 (1–3)
Education level No education, n (%) 196 (35.9) 123 (31.3) 0.148 319 (34.0)
Primary, n (%) 206 (37.7) 145 (36.9) — 351 (37.4)
Secondary and above, n (%) 144 (26.4) 125 (31.8) — 269 (28.6)
Religion Christian, n (%) 303 (55.5) 241 (61.3) 0.025 544 (57.9)
Muslim, n (%) 187 (34.2) 130 (33.1) — 317 (33.8)
Animist or no religion, n (%) 56 (10.3) 22 (5.6) — 78 (8.3)
Cohabiting with Partner only, n (%) 210 (38.5) 123 (31.3) 0.001 333 (35.5)
Partner and family, n (%) 166 (30.4) 147 (37.4) — 313 (33.3)
Family or family-in-law, n (%) 146 (26.7) 119 (30.3) — 265 (28.2)
Other, no partner, n (%) 24 (4.4) 4 (1.0) — 28 (3.0)
Declaring at least one co-spouse, n (%) 119 (21.8) 49 (12.5) ,0.001 168 (17.9)
Having remunerated activity, n (%) 280 (51.2) 179 (45.5) 0.083 459 (48.9)
Living in shared housing
b, n (%) 358 (65.6) 224 (57.0) 0.008 582 (62.0)
Choice prior to delivery of child feeding
at birth
Breast-feeding, n (%) 241 (44.1) NC — —
Formula feeding, n (%) 300 (55.0) — — —
No choice, n (%) 5 (0.90) — — —
Partner’s age Number in sample 194 367 — 561
20–29 y, n (%) 50 (25.8) 99 (27.0) 0.836 149 (26.6)
30–39 y, n (%) 105 (54.1) 189 (51.5) — 294 (52.4)
40 y and above, n (%) 39 (20.1) 79 (21.5) — 118 (21.0)
Partner’s level of education Number in sample 202 373 — 575
No education, n (%) 42 (20.8) 70 (18.8) 0.487 112 (19.5)
Primary, n (%) 25 (12.4) 54 (14.5) — 79 (13.7)
Secondary, n (%) 100 (49.5) 199 (53.3) — 299 (52.0)
Higher education, n (%) 35 (17.3) 50 (13.4) — 85 (14.8)
aComparison HIV-positive /HIV-negative, v
2 test or Mann-Whitney U-test.
bTypical housing in Abidjan with several houses organized around a yard, where inhabitants share kitchen and restroom and live in crowded accommodations.
IQR, interquartile range; NC, group was not concerned with the factor.
doi:10.1371/journal.pmed.0040342.t001
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Women and HIV Status Disclosuresure and whether or not the woman was engaged in
remunerated activity.
The majority of HIV-infected women disclosed their HIV
status to their partner before delivery. Among breastfeeding
HIV-infected women who disclosed their HIV status to their
partner, 55.7% disclosed before delivery, 17% between
delivery and the resumption of sexual activity, and 19%
between delivery and weaning. Among HIV-infected women
who did not breast-feed, 65.8% disclosed before delivery and
8% disclosed between delivery and resumption of sexual
activity.
Disclosure before delivery was related to child feeding
choice: among women who disclosed their HIV status before
delivery, 34.6% decided to breast-feed and 64.8% decided not
to breast-feed prior to delivery (v
2¼12.35, df¼1, p , 0.001).
Among the women who disclosed after delivery, we
observed peaks of disclosure just around the period of
weaning and around the resumption of sexual activity (Figure
1).
Partners’ HIV Testing
Overall, 184 (19.6%) partners were tested for HIV. Partners
of HIV-positive women were more likely to be tested than
partners of HIV-negative women (23.1% versus 14.8%, v
2 ¼
Table 2. Determinants of Women’s HIV Status Disclosure to Partners, among HIV-Infected Women: Univariate Analysis and Multivariate
Logistic Regression (Ditrame Plus ANRS 1201-1202-1253, Abidjan, 2001–2005)
Factor Category n
a Women Disclosing Their
HIV Status to Partner(s)
Multivariate
Analysis
b
% p-Value
c aOR
d 95% CI p-Value
e
Age, y — — 0.015 — — 0.110
18–19 31 22.6 — 1 — —
20–24 167 41.9 — 1.62 0.61–4.31 0.331
25–29 193 47.7 — 2.03 0.75–5.46 0.162
30–34 106 55.7 — 3.09 1.07–8.90 0.036
35 and above 49 49.0 — 2.94 0.93–9.32 0.066
Education level — — 0.308 — — 0.810
No education 196 42.3 — 1 — —
Primary 206 46.6 — 1.06 0.67–1.68 0.800
Secondary and above 144 50.7 — 1.19 0.70–2.02 0.520
Religion — — 0.659 — — 0.799
Christian 303 47.9 — 1 — —
Muslim 187 44.4 — 1.16 0.74–1.82 0.515
Animist or no religion 56 42.9 — 1.10 0.58–2.08 0.765
Cohabiting with — — ,0.001 — — ,0.001
Partner only 210 55.2 — 1 — —
Partner and family 166 51.8 — 0.89 0.57–1.40 0.637
Family or family-in-law 146 26.7 — 0.29 0.17–0.50 ,0.001
Other 24 45.8 — 0.64 0.25–1.64 0.355
Declaring at least one co-spouse — — ,0.001 — — —
No 427 50.1 — 1 — —
Yes 119 31.9 — 0.51 0.31–-0.83 0.007
Living in shared housing
f — — 0.010 — — —
No 188 53.7 — 1 — —
Yes 358 46.0 — 0.67 0.44–1.02 0.067
Remunerated activity — — 0.968 — — —
No 266 46.2 — 1 — —
Yes 280 46.1 — 1.15 0.78–1.69 0.471
Number of infants alive — — 0.955 — — —
  1 177 46.3 — 1 — —
. 1 369 46.1 — 0.67 0.42–1.06 0.086
Clinical AIDS stage — — 0.756 — — 0.763
Stage 1 189 47.6 — 1 — —
Stage 2 215 44.2 — 0.867 0.56–1.34 0.520
Stage 3 or 4 142 47.2 — 0.855 0.52–1.40 0.534
Infant feeding mode at birth of index infant
b — — 0.005 — — —
Breast-feeding 243 39.1 — 1 — —
Formula feeding 283 51.2 — 1.54 1.04–2.27 0.031
Death of index infant — — 0.625 — — —
No 487 45.8 — 1 — —
Yes 59 49.2 — 1.13 0.55–2.29 0.727
an indicates number of a total of 546 in group.
b20 women whose data are not available were excluded for analysis.
cv
2 test.
daOR, adjusted odds ratio.
eWald test.
fTypical housing in Abidjan with several houses organized around a yard, where inhabitants share kitchen and restroom and live in crowded accommodations.
doi:10.1371/journal.pmed.0040342.t002
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Women and HIV Status Disclosure10.04, df¼1, p¼0.002). Among the 184 couples HIV tested, 54
(29.4%) were seroconcordant HIV-positive, 56 (30.4%) were
seroconcordant HIV-negative and 74 (40.2%) were serodis-
cordant couples. In the serodiscordant couples, two women
were HIV-negative and 72 women were HIV-positive.
For partners of HIV-negative women, demographic varia-
bles such as education and marital status (monogamous or
polygamous) were not correlated with HIV testing (Table 3).
The only variable signiﬁcantly associated with partner HIV
testing was previous HIV testing of the partner (44.4% versus
14.1%, v
2 ¼ 6.452, df ¼ 1, p ¼ 0.011). For partners of HIV-
positive women, on the other hand, partners were more likely
to be tested if they were educated (46.3% versus 16.7%, v
2 ¼
12.12, df ¼ 1, p , 0.001), were informed of their wife’s
infection (37.7% versus 10.5%, v
2 ¼ 56.36, df ¼ 1, p , 0.001),
in a monogamous couple (27.6% versus 6.7%, v
2¼22.93, df¼
1, p , 0.001), and had previous HIV testing experience (100%
versus 22%, v
2 ¼ 20.22, df ¼ 1, p , 0.001).
Discussion
In this study, almost all (96.7%) women who had been
informed of their HIV-negative status notiﬁed their partner.
Among HIV-infected women, less than half (46.2%) had
disclosed to their partner at the end of the follow-up period.
We have also highlighted the existence of three privileged
moments for HIV-infected women’s disclosure to their
partner: before delivery, upon resumption of sexual activity,
and around early weaning for breast-feeding women. For
HIV-negative women, we had already described in a previous
study that most of them informed their partner of their
testing before delivery [7]. Only one in ﬁve male partners
were tested for HIV. Partners informed of their wife’s HIV
status were more likely to undertake HIV testing, in
particular when the woman tested HIV-positive.
This study was conducted within a population of women
participating in a research programme proposing systematic
prenatal HIV testing and counselling but not in the opera-
tional context of PMTCT services delivery. The psychosocial
support of women in our study may have been stronger than
in an operational context. Hence the proportions of women
who disclosed their HIV status to their partner and the
proportion of partners HIV tested may be higher than those
obtained in an operational context. Another weakness is that
we did not study the partner’s reaction over a long period of
time. Hence the negative reactions of partners may be
underestimated. However, two studies in Tanzania and
Burkina Faso had previously showed that after sharing
information, most male partners proved to be understanding
and the majority of the couples remained stable [18,19].
Despite these weaknesses, our prospective study design
provides reliable and original information on the timing of
women’s disclosure of their HIV status to their partner. Our
timing data were very precise before delivery (66% of
disclosure), because women were seen every other week.
After delivery, women were only seen every three months and
data were less precise, but even in this period we had precise
information on the relative position of the different events:
disclosure, resumption of sexual activity, and weaning.
Our results reveal that, in spite of the continual counselling
and psychosocial support provided within the Ditrame-Plus
programme, the proportion of HIV-infected women who
disclosed their status to their partner is comparable to that
observed in the context of a previous PMTCT research
programme conducted on the same sites in Abidjan and with
no speciﬁc support by the sociomedical team for notifying
the partner [20]. This lack of evolution over time underlines
the difﬁculties HIV-infected women encounter in discussing
their own HIV status within the couple and raises the
persistent fear of social stigma associated with HIV in this
context. Nevertheless, these HIV-infected women declared
during qualitative interviews published elsewhere [8] that
disclosing their status to their partner seemed essential to
them, so the women could beneﬁt from comfort and support
Table 3. Proportions of Male Partners Tested for HIV According to Women’s HIV Status (Ditrame Plus ANRS 1201-1202-1253, Abidjan,
2001–2005)
Factor Category HIV-Positive Women
a HIV-Negative Women
b
n Partner Tested (%) p-Value
c n Partner Tested(%) p-Value
c
Woman’s education level No education 196 16.3 0.003 123 13.0 0.235
Primary 206 23.3 — 145 12.4 —
Secondary and above 144 31.9 — 125 19.2 —
Woman has a co-spouse No 427 27.6 ,0.001 344 14.8 0.921
Yes 119 6.7 — 49 14.3 —
Woman lives with her partner No 170 13.5 ,0.001 123 12.2 0.334
Yes 376 27.4 — 270 15.9 —
Partner’s education level
d No education 42 16.7 ,0.001 70 8.6 0.074
Primary and above 160 46.3 — 303 17.2 —
Partner knows woman’s HIV status No 294 10.5 ,0.001 13 0 —
Yes 252 37.7 — 380 15.3 —
Woman’s partner previously tested for HIV No 540 22.0 ,0.001 384 14.1 0.030
Yes 6 100 — 9 44.4 —
aTotal women in HIV-positive group ¼ 546.
bTotal women in HIV-negative group ¼ 393.
cv
2 or Fisher exact tests.
dData are not available for 344 HIV-infected women and 20 HIV-negative women.
doi:10.1371/journal.pmed.0040342.t003
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Women and HIV Status Disclosureto make important decisions for their infant and the couple.
Most (82%) of the partners of HIV-infected women informed
were understanding and provided their wife with moral
support. Negative reactions of the male partner (violence,
separation) existed but they were rare.
The analysis of disclosure over time showed that two-thirds
of the HIV-infected women who disclosed their HIV status to
their partner reported they did so before delivery. This result
may be related to the fact that during pregnancy, women
were asked to say how they intended to feed the child they
were carrying, i.e., formula feeding from birth or exclusive
breast-feeding with early cessation at four months. Two-
thirds (64.8%) of women who had disclosed their HIV status
before delivery opted for formula feeding, versus 50% among
women who did not disclose before delivery. Indeed, in this
context, where breast-feeding is widely practiced and
prolonged [21], it was important for HIV-infected women
opting for formula feeding to receive their partner’s support.
Hence they were more likely to disclose their HIV status
before delivery, i.e., before implementation of the infant
feeding choice. This is an important factor to take into
account in the prevention of MTCT. Similarly, for women
who breast-fed their child at birth, the period around
weaning appeared to be a critical moment for disclosure to
the partner [22]. The median duration (4 mo) of total breast-
feeding among HIV-infected women in the Ditrame Plus
study was considerably shorter than what was previously
described in Abidjan where median duration was estimated
to be around 17 mo [21]. In the Ditrame Plus programme, we
observed that failure of early weaning was linked to pressure
from the woman’s family-in-law. [17]. Breast-feeding HIV-
infected women who had not disclosed their HIV status
before delivery may have chosen to do so at weaning time, in
order to justify early weaning to the partner and get his
support in front of the family and community. An earlier
study conducted in Abidjan and Bobo-Dioulasso noted that
the partner’s opinion was the ﬁrst obstacle to adoption of safe
infant feeding practices to prevent HIV transmission through
breast-feeding [23]. The implementation of alternatives to
prolonged breast-feeding for PMTCT depends heavily on the
conjugal and social environment of each HIV-infected
woman.
Finally, a third event appeared to be essential in the
disclosure process, the resumption of sexual activity after
delivery. When women were informed of their HIV infection,
they received counselling on preventing transmission via
sexual relations. When they resume sex, proposing the use of
condoms to their partner is complex and arouses suspicion if
the partner is unaware of his wife’s HIV status. Disclosing her
HIV infection may seem necessary to avoid HIV transmission
within the couple.
At these key moments for disclosure that we identiﬁed,
intensiﬁed psychosocial support for women may increase the
proportion of women who manage to disclose their HIV
status to their partner. The women who would beneﬁt from
such support around disclosure are those who encounter
difﬁculties in the present programme in talking with their
partner, i.e., mainly the youngest women with less conjugal
experience and those whose living conditions are not suitable
for conjugal conﬁdentiality (shared housing, no co-residence
with the male partner, or presence of a co-spouse).
Conjugal organisation seems to be an important determi-
nant of disclosure. Women cohabiting with their partner
were more likely to share their test result, regardless of their
HIV status. Similar results were observed in a Zambian study
on individual and couple HIV counselling and testing [24].
Cohabitation indeed provides more space and time for
discussing such sensitive issues as HIV infection. By contrast,
living in polygamous households or in shared housing reduces
the likelihood of women’s disclosure, probably due to
reduced conﬁdentiality. It seems that women who do not
live with their partner and/or who have a co-spouse are less
likely to trust their partner.
Only 19.6% of male partners were tested for HIV. The
programme did not offer any couple HIV counselling and
testing, but free HIV counselling and testing were available to
any willing partner. Three reasons may explain the small
proportion of men tested for HIV [7]: the fear of discovering
his HIV-positive status; the need to personally and actively
request HIV testing (unlike pregnant women, who were
offered HIV counselling and testing during antenatal care);
and the belief that HIV status matched the wife’s. This latter
reason, i.e., the belief that couples cannot be serodiscordant,
may explain why only 14.8% male partners of HIV-negative
women were tested. A similar result was found in Tanzania:
only 16% of partners informed of their wife’s HIV status said
they would like to go for testing [11].
Partners’ HIV testing was signiﬁcantly correlated to their
previous HIV testing experience, in addition to others factors
such as education level and sharing of woman’s HIV test
result. Earlier experience with HIV testing seems to diminish
the fear associated with the test, so it would be valuable to
multiply the occasions to be HIV tested.
In conclusion, our study suggests that the implementation
of speciﬁc psychosocial counselling and support for HIV-
infected women at the end of pregnancy, the period of early
weaning, and the resumption of sexual activity are important
to help women to disclose their HIV status to their partner.
This disclosure is an important step that could contribute to
improving women’s adherence to the advice given to prevent
postnatal and sexual HIV transmission.
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Background. Since the first reported case of AIDS (acquired immuno-
deficiency syndrome) in 1981, the number of people infected with the
human immunodeficiency virus (HIV), which causes AIDS, has risen
steadily. By the end of 2006, nearly 40 million people were infected, 25
million of them in sub-Saharan Africa. HIV is most often spread by having
unprotected sex with an infected partner. In Africa, most sexual
transmission of HIV is between partners in stable relationships—many
such couples do not adopt measures that prevent viral transmission,
such as knowing the HIV status of both partners and using condoms if
one partner is HIV-positive. HIV can also pass from a mother to her baby
during pregnancy, labor, or delivery, or through breastfeeding. Mother-
to-child transmission (MTCT) of HIV can be reduced by giving anti-HIV
drugs to the mother during pregnancy and labor and to her newborn
baby, and by avoiding breastfeeding or weaning the baby early.
Why Was This Study Done? Many African countries have programs for
prevention of MTCT (PMTCT) that offer pregnant women prenatal HIV
counseling and testing. As a result, women are often the first member of
a stable relationship to know their HIV status. PMTCT programs advise
women to disclose their HIV test result to their partner and to encourage
him to have an HIV test. But for many women, particularly those who are
HIV-positive, talking to their partner about HIV/AIDS is hard because of
fears of rejection (which could mean loss of housing and food) or
accusations of infidelity. Knowing more about when women disclose
their HIV status and what makes them decide to do so would help the
people running PMTCT programs to support women during the difficult
process of disclosure. In this study, the researchers have investigated
when and why women participating in a PMTCT research project in
Abidjan (Co ˆte d’Ivoire) told their partner about their HIV status and the
impact this disclosure had on their partner’s uptake of HIV testing.
What Did the Researchers Do and Find? At regular follow-up visits, the
researchers asked women in the Abidjan PMTCT project whether they
had told their partners their HIV status and whether they were breast-
feeding or had resumed sexual activity. Nearly all the women who tested
negative for HIV, but slightly fewer than half of the HIV-positive
(infected) women had told their partner about their HIV status by two
years after childbirth. Two-thirds of the HIV-positive women who
disclosed their status did so before delivery. Other key times for
disclosure were at early weaning (4 months after birth) for women who
breast-fed their babies, and when sexual activity resumed. HIV-positive
women who bottle fed their babies from birth were more likely to tell
their partners of their status than women who breast-fed. Factors that
prevented women disclosing their HIV status included living in a
polygamous relationship or living separately from their partners. Finally,
the researchers report that the partners of HIV-positive women who
disclosed their HIV status were about three times more likely to take an
HIV test than the partners of HIV-positive women who did not disclose.
What Do These Findings Mean? These findings identify three key times
when women who have had an HIV test during pregnancy are likely to
disclose their HIV status to their partner. The main one is before delivery
and relates, in part, to how the mother plans to feed her baby. To bottle
feed in Abidjan, women need considerable support from their partners
and this may be the impetus for disclosing their HIV status. Disclosure at
early weaning may reflect the woman’s need to enlist her partner’s
support for this unusual decision—the normal time for weaning in
Abidjan is 17 months. Finally, disclosure when sexual activity resumes
may be necessary so that the woman can explain why she wants to use
condoms. Although these findings need confirmation in other settings,
targeting counseling and support within PMTCT programs to these key
moments might help HIV-positive women to tell their partners about
their status. This, hopefully, would help to reduce sexual transmission of
HIV within stable relationships in sub-Saharan Africa.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040342.
  Information is available from the US National Institute of Allergy and
Infectious Diseases on HIV infection and AIDS and on HIV infection in
women
  HIV InSite has comprehensive information on all aspects of HIV/AIDS
  Women Children and HIV provides extensive information on preven-
tion of mother-to-child transmission of HIV in developing countries
  Information is available from Avert, an international AIDS charity, on
HIV and AIDS in Africa and on HIV and AIDS prevention
  AIDSinfo, a service of the US Department of Health and Human
Services provideshealth information for HIV-positive pregnant women
(in English and Spanish)
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